Related Experiment Video
Updated: Jul 5, 2026

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition
Published on: October 9, 2014
A G-tract element in apoptotic agents-induced alternative splicing
Yan Hai1, Wenguang Cao, Guodong Liu
1Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College. Kunming, China.
Abstract:
Alternative splicing of a single pre-mRNA transcript can produce protein isoforms that promote either cell growth or death. Here we show that Ro-31-8220 (Ro), an apoptotic agent that inhibits protein kinase C and activates the c-Jun N terminal kinase, decreased the proportion of the cell growth-promoting Bcl-xL splice variant. Targeted mutagenesis analyses narrowed down a critical sequence to a 16-nt G-tract element (Gt16). Transferring this element to a heterologous gene conferred Ro response on an otherwise constitutive exon. The Ro effect was reduced by okadaic acid, an inhibitor of protein phosphatases PP1 and PP2A, in a concentration-dependent manner. Search in the human genome followed by RT-PCR identified a group of genes that contain similar exonic G-tract elements and are responsive to Ro. Moreover, the Gt16 element also mediates the regulation of alternative splicing by other cell apoptosis-inducers particularly retinoic acid. Therefore, the G-tract element likely plays a role in the apoptotic agents-induced alternative splicing of a group of genes. The functions of these genes imply that this regulation will have impact on cell growth/death.
Insights
Alternative splicing regulates cell fate. A G-tract element (Gt16) mediates apoptotic agent-induced changes in splicing, impacting cell growth and death pathways.
Area of Science:
- Molecular Biology
- Cell Biology
- Genetics
Background:
- Alternative splicing generates protein diversity from a single pre-mRNA.
- Dysregulation of alternative splicing is implicated in various diseases.
Purpose of the Study:
- To investigate the molecular mechanisms by which apoptotic agents regulate alternative splicing.
- To identify specific sequence elements involved in this regulation.
Main Methods:
- Targeted mutagenesis to identify critical sequences.
- Gene transfer assays to assess functional significance.
- RT-PCR to screen for responsive genes in the human genome.
Main Results:
- Ro-31-8220 (Ro), an apoptotic agent, decreased the cell growth-promoting Bcl-xL splice variant.
- A 16-nucleotide G-tract element (Gt16) was identified as critical for this regulation.
- The Gt16 element conferred Ro-responsiveness to a heterologous gene.
- Okadaic acid inhibited the Ro-induced splicing changes in a dose-dependent manner.
- A group of genes containing similar G-tract elements were identified as responsive to Ro and retinoic acid.
Conclusions:
- The G-tract element (Gt16) is a key regulator of alternative splicing induced by apoptotic agents.
- This regulatory mechanism impacts genes involved in cell growth and death.
- The findings suggest a novel pathway for controlling cell fate through alternative splicing.
Related Concept Videos
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
RNA Splicing
RNA Splicing
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway

